Optimal Timing of Exercise Initiation Within a Lifestyle Weight Loss Program
| Status: | Completed |
|---|---|
| Conditions: | Obesity Weight Loss |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - 55 |
| Updated: | 1/17/2019 |
| Start Date: | November 2013 |
| End Date: | September 2018 |
The primary aim of this study is to evaluate the extent to which an exercise intervention
timed after diet-induced weight loss (rather than initiated at the same time) improves
exercise adherence and long-term weight loss. An 18 month randomized trial will be used to
compare two behavioral weight loss programs; standard behavioral therapy (Standard BT) and
sequential behavioral therapy (Sequential BT). The Standard BT group will receive a
traditional behavioral weight loss program where diet and exercise changes are initiated at
the same time. The Sequential BT group will receive a program that focuses solely on dietary
changes in the initial 6 months, and then incorporates exercise in the ensuing 6 months. Both
groups will be followed for 18 months to assess long-term weight loss. The hypothesis is that
delivery of diet and exercise interventions in sequence will result in improved adherence to
exercise and weight loss at 18 months when compared to a traditional program in which
identical diet and exercise interventions are initiated at the same time. This study could
identify a strategy that could aid in the development of more effective obesity treatment
programs and help more people achieve and sustain a weight loss.
timed after diet-induced weight loss (rather than initiated at the same time) improves
exercise adherence and long-term weight loss. An 18 month randomized trial will be used to
compare two behavioral weight loss programs; standard behavioral therapy (Standard BT) and
sequential behavioral therapy (Sequential BT). The Standard BT group will receive a
traditional behavioral weight loss program where diet and exercise changes are initiated at
the same time. The Sequential BT group will receive a program that focuses solely on dietary
changes in the initial 6 months, and then incorporates exercise in the ensuing 6 months. Both
groups will be followed for 18 months to assess long-term weight loss. The hypothesis is that
delivery of diet and exercise interventions in sequence will result in improved adherence to
exercise and weight loss at 18 months when compared to a traditional program in which
identical diet and exercise interventions are initiated at the same time. This study could
identify a strategy that could aid in the development of more effective obesity treatment
programs and help more people achieve and sustain a weight loss.
Inclusion Criteria:
- Age 18-55
- Body Mass Index 27-42 kilograms/meters squared
- Sedentary: defined as regular exercise of less than 100 minutes per week at moderate
intensity or greater during the previous 6 months
- No self-report of acute or chronic disease (heart disease, diabetes, gastrointestinal
disorders and orthopedic problems in particular)
- No plans to relocate or for extended travel (more than 1 week) within the next 18
months
- No current tobacco use
- Capable and willing to give informed consent, understand exclusion criteria, and
accept the randomized group assignment
- Live or work within 20 minutes of the University of Colorado Anschutz Health and
Wellness Center to ensure reasonable ability to comply with requirement to attend
group weight loss sessions and supervised exercise sessions. Exceptions can be made at
the discretion of the Study Principal Investigator (PI) on a case by case basis for
highly motivated subjects.
- For Females
- Not currently pregnant or lactating
- Not pregnant within the past 6 months
- Not planning to become pregnant in the next 18 months
- Sexually active women of childbearing potential may be enrolled if they have had
a tubal ligation or use a reliable means of contraception.
Exclusion Criteria:
- Presence or history of health problems which would affect appetite, food intake,
energy metabolism, or ability to optimally participate in the exercise component
including: diabetes, cardiovascular disease, peripheral vascular disease,
cerebrovascular disease, uncontrolled hypertension, uncontrolled hyper or
hypothyroidism, cancer (within the last 5 years, except skin cancer), human
immunodeficiency virus (HIV) infection, significant gastrointestinal, pulmonary,
renal, musculoskeletal, neurologic, or hematologic disease
- Symptoms suggestive of cardiovascular disease: chest pain, shortness of breath at rest
or with mild exertion, syncope
- Abnormal resting electrocardiogram (ECG): serious arrhythmias, including multifocal
Premature Ventricular Contractions (PVCs), frequent PVC's (defined as 10 or more per
minute), ventricular tachycardia (defined as runs of 3 or more successive PVC's), or
sustained atrial tachyarrhythmia; 2nd or 3rd degree A-V block, corrected QT interval >
480 millisecond or other significant conduction defects
- Triglycerides > 400 milligram/deciliter (md/dL) or Low-Density Lipoprotein (LDL)
cholesterol > 190 mg/dL
- Use of prescription or over-the-counter medications known to affect appetite, weight,
heart rate response to exercise, or energy metabolism
- Use of systemic steroids (other than Oral Contraceptive Pills)
- Use of obesity pharmacotherapeutic agents within the last 6 months
- History of surgical procedure for weight loss
- History of major surgery within the past 3 months
- Current alcohol or substance abuse
- History of clinically diagnosed eating disorders including anorexia nervosa or bulimia
- Current severe depression or history of severe depression within the previous year
- History of other significant psychiatric illness (e.g. psychosis, schizophrenia,
mania, bipolar disorder) which in the opinion of the Study MD would interfere with
ability to adhere to dietary or exercise interventions
- Currently participating in or planning to participate in any formal weight loss or
physical activity programs or clinical trials
- Weight loss or gain of > 5% in past 6 months for any reason except post-partum weight
loss
- Participation in a weight loss program using the Colorado Weigh curriculum within the
past 3 years (exceptions can be made at the discretion of the study PI on a
case-by-case basis).
We found this trial at
1
site
Aurora, Colorado 80022
Principal Investigator: Victoria Catenacci, MD
Click here to add this to my saved trials
